A recent article from The Intercept_ discussed the Biden administration’s exploration of psychedelic treatments for PTSD and depression. A federal letter revealed that Biden anticipates approval for MDMA and psilocybin as designated breakthrough therapies. The correspondence dates back to May, but was just recently shared with the public. Apparently the administration is exploring the idea of creating a federal task force to monitor psychedelic treatment developments. The full letter can be seen here.
Biden Prepares for Psychedelic Therapy Approval
A new letter from the Health and Human Services Department suggests FDA approval of MDMA and psilocybin treatments is on the horizon.
Aug 2, 2022
INTRODUCING! The Latest Trends for Life Sciences at PACK EXPO Southeast
The exciting new PACK EXPO Southeast 2025 unites all vertical markets in one dynamic hub, generating more innovative answers to packaging challenges for life sciences products. Don’t miss this extraordinary opportunity for your business!
Read More